PREVIOUS
✖
Apretude
December 27 , 2021
1111 days
898
0
- The Food and Drug Administration (FDA) of the USA approved the world’s first injectable medication for reducing the risk of acquiring HIV.
- Apretude is an injectable drug.
- Its generic name is “cabotegravir extended-release injectable suspension”.
- The drug provides an alternative to daily pills for HIV prevention, like Truvada and Descovy.
- These pills are effective up to 99% at preventing the sexual transmission of HIV.
- However, it must be taken every day to be effective.
Leave a Reply
Your Comment is awaiting moderation.